Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 4051763, 8 pages
https://doi.org/10.1155/2017/4051763
Research Article

Preparation and Characterization of Hyaluronic Acid-Polycaprolactone Copolymer Micelles for the Drug Delivery of Radioactive Iodine-131 Labeled Lipiodol

1Office of Research and Development, Kaohsiung Medical University, Kaohsiung 807, Taiwan
2Center for Infectious Disease and Cancer Research, Kaohsiung Medical University, Kaohsiung 807, Taiwan
3Department of Biomedical Engineering, National Yang-Ming University, Taipei 112, Taiwan
4Invasive Cardiac Laboratory, Tan Tock Seng Hospital, Singapore 308433
5Department of Chemistry, Chung Yuan Christian University, Taoyuan 320, Taiwan
6Department of Pathology, Changhua Christian Hospital, Changhua 500, Taiwan
7Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung 807, Taiwan
8Department of Nuclear Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
9Department of Medical Laboratory Science and Biotechnology, Kaohsiung Medical University, Kaohsiung 807, Taiwan
10Department of Laboratory Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan
11Department of Chemistry, National Sun Yat-sen University, Kaohsiung 804, Taiwan
12Graduate Institute of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 807, Taiwan
13Institute of Medical Science and Technology, National Sun Yat-sen University, Kaohsiung 804, Taiwan
14Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan

Correspondence should be addressed to Yu-Chang Tyan; wt.ude.umk@naytcy

Received 21 September 2016; Accepted 5 December 2016; Published 3 January 2017

Academic Editor: Yue W. Huang

Copyright © 2017 Shih-Cheng Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Richter, J. Rassweiler, G. W. Kauffmann, W. Wenz, and D. B. Crawford, “Experimental study of the effectiveness of capillary embolization using contrast-enhanced ethibloc,” Investigative Radiology, vol. 19, no. 1, pp. 36–44, 1984. View at Publisher · View at Google Scholar · View at Scopus
  2. J.-L. Raoul, P. Bourguet, J.-F. Bretagne et al., “Hepatic artery injection of I-131-labeled lipiodol. Part I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases,” Radiology, vol. 168, no. 2, pp. 541–545, 1988. View at Publisher · View at Google Scholar · View at Scopus
  3. R. E. Hind, M. Loizidou, S. Perring et al., “Biodistribution of Lipiodol following hepatic arterial injection,” British Journal of Surgery, vol. 79, no. 9, pp. 952–954, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Higashi, M. Shimizu, T. Nakashima et al., “Arterial-injection chemotherapy for hepatocellular carcinoma using monodispersed poppy-seed oil microdroplets containing fine aqueous vesicles of epirubicin. Initial medical application of a membrane-emulsification technique,” Cancer, vol. 75, no. 6, pp. 1245–1254, 1995. View at Publisher · View at Google Scholar · View at Scopus
  5. J. R. Buscombe, “Interventional nuclear medicine in hepatocellular carcinoma and other tumours,” Nuclear Medicine Communications, vol. 23, no. 9, pp. 837–841, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Abe and M. Otsuki, “Styrene maleic acid neocarzinostatin treatment for hepatocellular carcinoma,” Current Medicinal Chemistry—Anti-Cancer Agents, vol. 2, no. 6, pp. 715–726, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Fujiyama, J. Shibata, S. Maeda et al., “Phase I clinical study of a novel lipophilic platinum complex (SM-11355) in patients with hepatocellular carcinoma refractory to cisplatin/lipiodol,” British Journal of Cancer, vol. 89, no. 9, pp. 1614–1619, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Towu, R. Al-Mufti, L. Spitz, K. Marron, and M. Winslet, “Uptake of Lipiodol™-cytotoxic conjugates by hepatoblastoma cells,” British Journal of Surgery, vol. 89, no. 4, pp. 437–441, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. E. Towu, R. Al-Mufti, M. Winslet, L. Quaglia, and P. Losty, “Uptake of lipiodol-cytotoxics conjugates by hepatocellular carcinoma cells,” Journal of Pediatric Surgery, vol. 39, no. 2, pp. 203–206, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Sato, “Locoregional immuno(bio)therapy for liver metastases,” Seminars in Oncology, vol. 29, no. 2, pp. 160–167, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-S. Guan, Y. Hu, and Y. Liu, “Multidetector-row computed tomography in the management of hepatocellular carcinoma with transcatheter arterial chemoembolization,” Journal of Gastroenterology and Hepatology, vol. 21, no. 6, pp. 941–946, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. H. Risse, C. Menzel, F. Grünwald, H. Strunk, H.-J. Biersack, and H. Palmedo, “Therapy of hepatocellular cancer with iodine-131-Lipiodol,” Romanian Journal of Gastroenterology, vol. 13, no. 2, pp. 119–124, 2004. View at Google Scholar · View at Scopus
  13. B. Lambert and C. Van De Wiele, “Treatment of hepatocellular carcinoma by means of radiopharmaceuticals,” European Journal of Nuclear Medicine and Molecular Imaging, vol. 32, no. 8, pp. 980–989, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. B. Lambert, H. van Vlierberghe, R. Troisi, and L. Defreyne, “Radionuclide therapy for hepatocellular carcinoma,” Acta Gastro-Enterologica Belgica, vol. 73, no. 4, pp. 484–488, 2010. View at Google Scholar · View at Scopus
  15. M. M. Smith and P. Ghosh, “The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment,” Rheumatology International, vol. 7, no. 3, pp. 113–122, 1987. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Saari, Y. T. Konttinen, C. Friman, and T. Sorsa, “Differential effects of reactive oxygen species on native synovial fluid and purified human umbilical cord hyaluronate,” Inflammation, vol. 17, no. 4, pp. 403–415, 1993. View at Publisher · View at Google Scholar · View at Scopus
  17. B. P. Toole, A. Zoltan-Jones, S. Misra, and S. Ghatak, “Hyaluronan: a critical component of epithelial-mesenchymal and epithelial-carcinoma transitions,” Cells Tissues Organs, vol. 179, no. 1-2, pp. 66–72, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. N. Itano, T. Sawai, F. Atsumi et al., “Selective expression and functional characteristics of three mammalian hyaluronan synthases in oncogenic malignant transformation,” The Journal of Biological Chemistry, vol. 279, no. 18, pp. 18679–18687, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. R. K. Sironen, M. Tammi, R. Tammi, P. K. Auvinen, M. Anttila, and V.-M. Kosma, “Hyaluronan in human malignancies,” Experimental Cell Research, vol. 317, no. 4, pp. 383–391, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. G. Bharadwaj, J. L. Kovar, E. Loughman, C. Elowsky, G. G. Oakley, and M. A. Simpson, “Spontaneous metastasis of prostate cancer is promoted by excess hyaluronan synthesis and processing,” American Journal of Pathology, vol. 174, no. 3, pp. 1027–1036, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. L. Zhang, J. Yao, J. Zhou, T. Wang, and Q. Zhang, “Glycyrrhetinic acid-graft-hyaluronic acid conjugate as a carrier for synergistic targeted delivery of antitumor drugs,” International Journal of Pharmaceutics, vol. 441, no. 1-2, pp. 654–664, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Wang, Z. Xu, R. Zhang, W. Li, L. Yang, and Q. Hu, “A facile approach to construct hyaluronic acid shielding polyplexes with improved stability and reduced cytotoxicity,” Colloids and Surfaces B: Biointerfaces, vol. 84, no. 1, pp. 259–266, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. T. S. Jhuang, Assessing the structure stability and specificity for the hepatocellular carcinoma cells of HA-modified micelle packed with radioactive Iodine-131 lipiodol [M.S. thesis], Department of Medical Imaging and Radiological Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan, 2013.
  24. J.-G. Lo, A.-Y. Wang, Y.-Y. Wei, W.-Y. Lui, C.-W. Chi, and W.-K. Chan, “Preparation of [131I]lipiodol as a hepatoma therapeutic agent,” International Journal of Radiation Applications and Instrumentation A, vol. 43, no. 12, pp. 1431–1435, 1992. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kalyanasundaram and J. K. Thomas, “Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems,” Journal of the American Chemical Society, vol. 99, no. 7, pp. 2039–2044, 1977. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Aguiar, P. Carpena, J. A. Molina-Bolívar, and C. C. Ruiz, “On the determination of the critical micelle concentration by the pyrene 1:3 ratio method,” Journal of Colloid and Interface Science, vol. 258, no. 1, pp. 116–122, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. K. Y. Choi, O. F. Silvestre, X. Huang et al., “A nanoparticle formula for delivering siRNA or miRNAs to tumor cells in cell culture and in vivo,” Nature Protocols, vol. 9, no. 8, pp. 1900–1915, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Yang, C. Li, L. Zhang, M. Li, and P. Zhou, “A promising hepatocyte-like cell line, CCL-13, exhibits good liver function both in vitro and in an acute liver failure model,” Transplantation Proceedings, vol. 45, no. 2, pp. 688–694, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. J.-Z. Du, D.-P. Chen, Y.-C. Wang et al., “Synthesis and micellization of amphiphilic brush—coil block copoclymer based on poly(ϵ-caprolactone) and PEGylated polyphosphoester,” Biomacromolecules, vol. 7, no. 6, pp. 1898–1903, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. X. Gao, B. Wang, X. Wei et al., “Preparation, characterization and application of star-shaped PCL/PEG micelles for the delivery of doxorubicin in the treatment of colon cancer,” International Journal of Nanomedicine, vol. 8, pp. 971–982, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. H. Zhu, J. Cao, S. Cui, Z. Qian, and Y. Gu, “Enhanced tumor targeting and antitumor efficacy via hydroxycamptothecin-encapsulated folate-modified N-succinyl-N′-octyl chitosan micelles,” Journal of Pharmaceutical Sciences, vol. 102, no. 4, pp. 1318–1332, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. D. Zhou, G. Zhang, and Z. Gan, “c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer,” Journal of Controlled Release, vol. 169, no. 3, pp. 204–210, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Shahin and A. Lavasanifar, “Novel self-associating poly(ethylene oxide)-b-poly(epsilon-caprolactone) based drug conjugates and nano-containers for paclitaxel delivery,” International Journal of Pharmaceutics, vol. 389, no. 1-2, pp. 213–222, 2010. View at Publisher · View at Google Scholar
  34. Q. Wang, J. Jiang, W. Chen, H. Jiang, Z. Zhang, and X. Sun, “Targeted delivery of low-dose dexamethasone using PCL–PEG micelles for effective treatment of rheumatoid arthritis,” Journal of Controlled Release, vol. 230, pp. 64–72, 2016. View at Publisher · View at Google Scholar
  35. H. Danafar, A. Sharafi, H. Kheiri Manjili, and S. Andalib, “Sulforaphane delivery using mPEG-PCL co-polymer nanoparticles to breast cancer cells,” Pharmaceutical Development and Technology, 2016. View at Publisher · View at Google Scholar
  36. Z. Karami, S. Sadighian, K. Rostamizadeh, M. Parsa, and S. Rezaee, “Naproxen conjugated mPEG-PCL micelles for dual triggered drug delivery,” Materials Science and Engineering C, vol. 61, pp. 665–673, 2016. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Wu, G. Tian, W. Yu, G. Jia, T. Sun, and Z. Gao, “pH-responsive hyaluronic acid-based mixed micelles for the hepatoma-targeting delivery of doxorubicin,” International Journal of Molecular Sciences, vol. 17, no. 4, p. 364, 2016. View at Publisher · View at Google Scholar
  38. S. Zheng, Z. Jin, J. Han et al., “Preparation of HIFU-triggered tumor-targeted hyaluronic acid micelles for controlled drug release and enhanced cellular uptake,” Colloids and Surfaces B: Biointerfaces, vol. 143, pp. 27–36, 2016. View at Publisher · View at Google Scholar
  39. Y. Zhong, K. Goltsche, L. Cheng et al., “Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo,” Biomaterials, vol. 84, pp. 250–261, 2016. View at Publisher · View at Google Scholar
  40. X. Han, Z. Wang, M. Wang et al., “Liver-targeting self-assembled hyaluronic acid-glycyrrhetinic acid micelles enhance hepato-protective effect of silybin after oral administration,” Drug Delivery, vol. 23, no. 5, pp. 1818–1829, 2016. View at Publisher · View at Google Scholar · View at Scopus